Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ehrmann

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
ACS Chemical Biology|April 17, 2018
Identification of Noncatalytic Lysine Residues from Allosteric Circuits via Covalent ProbesJens Bongard, Marian Lorenz, Ingrid R Vetter, et al.
The EMBO Journal|November 1, 2016
VCP/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagyChrisovalantis Papadopoulos, Philipp Kirchner, Monika Bug, et al.
ACS Chemical Biology|November 20, 2019
Adoption of a Turn Conformation Drives the Binding Affinity of p53 C-Terminal Domain Peptides to 14-3-3σAve Kuusk, João Filipe Neves, Kenny Bravo-Rodriguez, et al.
The Journal of Biological Chemistry|September 18, 2025
The serine protease HTRA1 targets tau fibrils and provides a proteolytic barrier against pathogenic protein conformationsBirte Hagemeier, Kamilla Ripkens, Nina Schulze, et al.
BMC Cancer|July 9, 2016
Epigenetic silencing of serine protease HTRA1 drives polyploidyNina Schmidt, Inga Irle, Kamilla Ripkens, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2022
An allosteric HTRA1-calpain 2 complex with restricted activation profileJuliana Rey, Maike Breiden, Vanda Lux, et al.
Molecular Cancer Research : MCR|July 31, 2010
The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 proteinMara Campioni, Anna Severino, Lucrezia Manente, et al.
Arthritis and Rheumatism|April 29, 2006
Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritisPeter J Richards, Mari A Nowell, Sankichi Horiuchi, et al.
Nature Communications|February 17, 2017
Tailored protein encapsulation into a DNA host using geometrically organized supramolecular interactionsAndreas Sprengel, Pascal Lill, Pierre Stegemann, et al.
Chemmedchem|April 5, 2019
Chemical Validation of DegS As a Target for the Development of Antibiotics with a Novel Mode of ActionJens Bongard, Anna Laura Schmitz, Alex Wolf, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
ACS Chemical Biology|April 17, 2018
Identification of Noncatalytic Lysine Residues from Allosteric Circuits via Covalent ProbesJens Bongard, Marian Lorenz, Ingrid R Vetter, et al.
The EMBO Journal|November 1, 2016
VCP/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagyChrisovalantis Papadopoulos, Philipp Kirchner, Monika Bug, et al.
ACS Chemical Biology|November 20, 2019
Adoption of a Turn Conformation Drives the Binding Affinity of p53 C-Terminal Domain Peptides to 14-3-3σAve Kuusk, João Filipe Neves, Kenny Bravo-Rodriguez, et al.
The Journal of Biological Chemistry|September 18, 2025
The serine protease HTRA1 targets tau fibrils and provides a proteolytic barrier against pathogenic protein conformationsBirte Hagemeier, Kamilla Ripkens, Nina Schulze, et al.
BMC Cancer|July 9, 2016
Epigenetic silencing of serine protease HTRA1 drives polyploidyNina Schmidt, Inga Irle, Kamilla Ripkens, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2022
An allosteric HTRA1-calpain 2 complex with restricted activation profileJuliana Rey, Maike Breiden, Vanda Lux, et al.
Molecular Cancer Research : MCR|July 31, 2010
The serine protease HtrA1 specifically interacts and degrades the tuberous sclerosis complex 2 proteinMara Campioni, Anna Severino, Lucrezia Manente, et al.
Arthritis and Rheumatism|April 29, 2006
Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritisPeter J Richards, Mari A Nowell, Sankichi Horiuchi, et al.
Nature Communications|February 17, 2017
Tailored protein encapsulation into a DNA host using geometrically organized supramolecular interactionsAndreas Sprengel, Pascal Lill, Pierre Stegemann, et al.
Chemmedchem|April 5, 2019
Chemical Validation of DegS As a Target for the Development of Antibiotics with a Novel Mode of ActionJens Bongard, Anna Laura Schmitz, Alex Wolf, et al.
Pageof 9